Sort by
Refine Your Search
-
our undergraduate and graduate students are taught by the same outstanding faculty. Twenty-six specialized research centers, along with three institutes for advanced studies and a GIS CORE facility
-
. Requirements: Qualified applicants must hold an earned doctorate (PhD) or terminal degree in a health-related field such as Doctorate in Health Education/Public Health, Doctorate in Chiropractic (DC), Doctorate
-
hold a minimum of a Master's degree in a related field with preference given to doctoral candidates (ABD) or (PhD) in an exercise/health-related field. Certifications from ACSM, CHES, Registered
-
. The department has academic programs at the BS, MS, and PhD levels in electrical and computer engineering. The ECE department is located in a new, well-equipped research building. Primary areas of research
-
academic writing to diverse students at the college/university level Preferred Qualifications: PhD specializing in rhetoric, composition, writing studies, or a related field Demonstrated excellence in
-
Education (ACPE). MS and PhD programs in Pharmaceutical Sciences launched in fall 2022 to further advance the School's translational, clinical and outcomes research within the changing landscape of drug
-
: Applicants should hold a PhD in global health, or a related field, by the start of this appointment. The successful candidate will also have teaching experience, with experience in teaching global public
-
, Binghamton University's distinctive first-year research program in the Humanities and Social Sciences. The position begins August 2024. PhD in hand by appointment. The Source Project is a sequence of two, four
-
to apply. Additional information about the Mechanical Engineering Department at Binghamton University can be found online at: http://www.binghamton.edu/me/ Requirements: Candidates must have a PhD in
-
Assistant Professor Pharmacological/Drug Development Approaches for Aging or Aging-related Disorders
Education (ACPE). MS and PhD programs in Pharmaceutical Sciences launched in fall 2022 to further advance the School's translational, clinical and outcomes research within the changing landscape of drug